Oral administration of the 11β-hydroxysteroid-dehydrogenase type 1 inhibitor RO5093151 to patients with glaucoma: an adaptive, randomised, placebo-controlled clinical study

por Schwab, Dietmar, Sturm, Carolina, Portron, Agnès, Fuerst-Recktenwald, Sabine, Hainzl, Dominik, Jordan, Paul, Stewart, William C, Tepedino, Michael E, DuBiner, Harvey
Publicado 2017